Renzenbrink & Partner advised Cable Connectivity Group on the deal. Cable Connectivity Group, a portfolio company of Torqx Capital Partners, announced the acquisition of ConCab kabel GmbH....
You must be a Standard 1 Year member to access this content.
Renzenbrink & Partner advised Cable Connectivity Group on the deal. Cable Connectivity Group, a portfolio company of Torqx Capital Partners, announced the acquisition of ConCab kabel GmbH....
You must be a Standard 1 Year member to access this content.
Annerton advised Coinpanion on the deal. The Austrian crypto start-up Coinpanion has brought three valuable partners on board – the German institutions Bankhaus Scheich, Bankhaus von...
You must be a Standard 1 Year member to access this content.
Arntzen de Besche assisted Sweco on the deal. CLP has assisted the shareholders of Arcasa Arkitekter. Sweco expands in sustainable residential development by acquiring Norwegian company Arcasa...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Inyova on the deal. Inyova launched a Crowdinvesting campaign. Inyova is the leading impact investing platform in Europe and managed approximately CHF 173 million...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Inyova on the deal. Inyova launched a Crowdinvesting campaign. Inyova is the leading impact investing platform in Europe and managed approximately CHF 173 million...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Five T on the deal. F10, the leading innovation ecosystem for FinTech and InsurTech, announced the closing of a new funding round in...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Five T on the deal. F10, the leading innovation ecosystem for FinTech and InsurTech, announced the closing of a new funding round in...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients...
You must be a Standard 1 Year member to access this content.
Homburger advised Sonova on the deal. Sonova Holding AG, a global leader in innovative hearing care solutions, successfully placed CHF 450 m Bonds. The Bonds are governed by...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Engimmune Therapeutics on the deal. Vischer advised the investors Pureos Bio-ventures and Novo Holdings. Engimmune Therapeutics completed a CHF 15.5m seed financing round co-led...
You must be a Standard 1 Year member to access this content.
